Virtual screening strategies in drug discovery: a critical review
A Lavecchia, C Di Giovanni - Current medicinal chemistry, 2013 - ingentaconnect.com
Virtual screening (VS) is a powerful technique for identifying hit molecules as starting points
for medicinal chemistry. The number of methods and softwares which use the ligand and …
for medicinal chemistry. The number of methods and softwares which use the ligand and …
Recognizing pitfalls in virtual screening: a critical review
The aim of virtual screening (VS) is to identify bioactive compounds through computational
means, by employing knowledge about the protein target (structure-based VS) or known …
means, by employing knowledge about the protein target (structure-based VS) or known …
CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction
Y Xu, S Wang, Q Hu, S Gao, X Ma, W Zhang… - Nucleic acids …, 2018 - academic.oup.com
CavityPlus is a web server that offers protein cavity detection and various functional
analyses. Using protein three-dimensional structural information as the input, CavityPlus …
analyses. Using protein three-dimensional structural information as the input, CavityPlus …
[HTML][HTML] Open-source platform to benchmark fingerprints for ligand-based virtual screening
S Riniker, GA Landrum - Journal of cheminformatics, 2013 - Springer
Similarity-search methods using molecular fingerprints are an important tool for ligand-
based virtual screening. A huge variety of fingerprints exist and their performance, usually …
based virtual screening. A huge variety of fingerprints exist and their performance, usually …
Integrating virtual screening and combinatorial chemistry for accelerated drug discovery
F López-Vallejo, T Caulfield… - … Chemistry & High …, 2011 - ingentaconnect.com
Virtual screening is increasingly being used in drug discovery programs with a growing
number of successful applications. Experimental methodologies developed to speed up the …
number of successful applications. Experimental methodologies developed to speed up the …
SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening
X Liu, H Jiang, H Li - Journal of chemical information and …, 2011 - ACS Publications
We developed a novel approach called SHAFTS (SHA pe-F ea T ure S imilarity) for 3D
molecular similarity calculation and ligand-based virtual screening. SHAFTS adopts a hybrid …
molecular similarity calculation and ligand-based virtual screening. SHAFTS adopts a hybrid …
How far can virtual screening take us in drug discovery?
S Kar, K Roy - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Virtual screening (VS) has emerged as an important tool in identifying bioactive
compounds through computational means, by employing knowledge about the protein target …
compounds through computational means, by employing knowledge about the protein target …
Ligand-based virtual screening approach using a new scoring function
A Hamza, NN Wei, CG Zhan - Journal of chemical information and …, 2012 - ACS Publications
In this study, we aimed to develop a new ligand-based virtual screening approach using an
effective shape-overlapping procedure and a more robust scoring function (denoted by the …
effective shape-overlapping procedure and a more robust scoring function (denoted by the …
Comprehensive comparison of ligand-based virtual screening tools against the DUD data set reveals limitations of current 3D methods
V Venkatraman, VI Pérez-Nueno… - Journal of chemical …, 2010 - ACS Publications
In recent years, many virtual screening (VS) tools have been developed that employ different
molecular representations and have different speed and accuracy characteristics. In this …
molecular representations and have different speed and accuracy characteristics. In this …
Machine learning-and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease
T Qin, X Gao, L Lei, J Feng, W Zhang, Y Hu… - European Journal of …, 2023 - Elsevier
Farnesoid X receptor (FXR) is a promising target for drug discovery against nonalcoholic
fatty liver disease (NAFLD). However, no FXR agonist has been approved for NAFLD so far …
fatty liver disease (NAFLD). However, no FXR agonist has been approved for NAFLD so far …